• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颌骨散发性骨化性纤维瘤中的CDC73基因突变

CDC73 gene mutations in sporadic ossifying fibroma of the jaws.

作者信息

Chen Yan, Hu Da-Yan, Wang Ting-Ting, Zhang Ran, Dong Qing, Xu Zhi-Xiu, Wang Lin, Li Tie-Jun

机构信息

Department of Oral Pathology, Peking University School and Hospital of Stomatology, 22 South Zhongguancun Avenue, Haidian District, Beijing, 100081, People's Republic of China.

Department of Oral Medicine, North China University of Science and Technology, School and Hospital of Stomatology, 82 South Construction Road, Lubei District, Tangshan, 063000, People's Republic of China.

出版信息

Diagn Pathol. 2016 Sep 22;11(1):91. doi: 10.1186/s13000-016-0532-0.

DOI:10.1186/s13000-016-0532-0
PMID:27658992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5034632/
Abstract

BACKGROUND

The tumor suppressor gene CDC73 was found to be associated with hyperparathyroidism-jaw tumor syndrome (HPT-JT), which is characterized by parathyroid adenoma or carcinoma, ossifying fibroma (OF) of the jaws, and renal and uterine lesions. Mutations in CDC73 have also been frequently detected in sporadic parathyroid carcinomas and renal tumors. However, the prevalence and range of CDC73 mutations in sporadic OFs have not been established.

METHODS

We directly sequenced coding and flanking splice junctional regions of CDC73 in 40 cases of sporadic OF of the jaws. We also used immunohistochemistry to detect parafibromin, the protein product of CDC73, in those cases.

RESULTS

Two novel CDC73 mutations were identified in 2 of the 40 cases (5 %). Both were somatic mutations located in exon 1 of the coding region. Strong parafibromin expression was detected in all 40 cases, irrespective of the presence of CDC73 mutations.

CONCLUSIONS

Mutations inCDC73 were rare in sporadic OF of the jaws, but may affect the pathogenesis of a small subset of tumors of this type.

摘要

背景

肿瘤抑制基因CDC73被发现与甲状旁腺功能亢进-颌骨肿瘤综合征(HPT-JT)相关,该综合征的特征为甲状旁腺腺瘤或癌、颌骨骨化性纤维瘤(OF)以及肾脏和子宫病变。在散发性甲状旁腺癌和肾肿瘤中也经常检测到CDC73突变。然而,散发性OF中CDC73突变的发生率和范围尚未明确。

方法

我们对40例散发性颌骨OF的CDC73编码区和侧翼剪接连接区进行了直接测序。我们还使用免疫组织化学方法检测了这些病例中CDC73的蛋白产物 parafibromin。

结果

在40例病例中的2例(5%)中鉴定出两个新的CDC73突变。两者均为位于编码区第1外显子的体细胞突变。无论是否存在CDC73突变,在所有40例病例中均检测到强parafibromin表达。

结论

CDC73突变在散发性颌骨OF中罕见,但可能影响一小部分此类肿瘤的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e737/5034632/a16a0d400477/13000_2016_532_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e737/5034632/b0c931ba41be/13000_2016_532_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e737/5034632/a16a0d400477/13000_2016_532_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e737/5034632/b0c931ba41be/13000_2016_532_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e737/5034632/a16a0d400477/13000_2016_532_Fig2_HTML.jpg

相似文献

1
CDC73 gene mutations in sporadic ossifying fibroma of the jaws.颌骨散发性骨化性纤维瘤中的CDC73基因突变
Diagn Pathol. 2016 Sep 22;11(1):91. doi: 10.1186/s13000-016-0532-0.
2
Parafibromin Abnormalities in Ossifying Fibroma.骨化性纤维瘤中的副纤维瘤蛋白异常
J Endocr Soc. 2021 May 8;5(7):bvab087. doi: 10.1210/jendso/bvab087. eCollection 2021 Jul 1.
3
Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.一名有甲状旁腺功能亢进-颌骨肿瘤综合征病史且已治愈的全身性骨纤维囊性骨炎患者的肿瘤抑制基因突变:病例报告及遗传病理生理学综述
J Oral Maxillofac Surg. 2015 Jan;73(1):194.e1-9. doi: 10.1016/j.joms.2014.09.008. Epub 2014 Sep 28.
4
Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.细胞分裂周期蛋白 73 同源物(CDC73)突变与甲状旁腺功能亢进-颌骨肿瘤综合征(HPT-JT)和甲状旁腺瘤有关。
Hum Mutat. 2010 Mar;31(3):295-307. doi: 10.1002/humu.21188.
5
Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.在甲状旁腺癌患者中,描述一名患有甲状旁腺功能亢进-颌骨肿瘤而无杂合性缺失的新型 CDC73 基因突变。
Endocr J. 2019 Apr 25;66(4):319-327. doi: 10.1507/endocrj.EJ18-0387. Epub 2019 Feb 22.
6
Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family.一个三代甲状旁腺功能亢进-颌骨肿瘤(HPT-JT)综合征家系中 CDC73(exon4-10)大片段基因内缺失。
BMC Med Genet. 2017 Aug 3;18(1):83. doi: 10.1186/s12881-017-0445-0.
7
Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.细胞分裂周期73基因缺失的小鼠会发生甲状旁腺和子宫肿瘤:一种甲状旁腺功能亢进-颌骨肿瘤综合征的模型。
Oncogene. 2017 Jul 13;36(28):4025-4036. doi: 10.1038/onc.2017.43. Epub 2017 Mar 13.
8
A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome.一个患有甲状旁腺功能亢进-颌骨肿瘤(HPT-JT)综合征的意大利家族中的一种新型CDC73基因突变。
Cell Oncol (Dordr). 2014 Aug;37(4):281-8. doi: 10.1007/s13402-014-0187-3. Epub 2014 Aug 12.
9
Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of Gene and Parafibromin-Deficient Tumours.甲状旁腺功能亢进-颌骨肿瘤综合征的研究进展:从内分泌学角度到基因和副甲状腺素缺乏性肿瘤谱。
Int J Mol Sci. 2024 Feb 15;25(4):2301. doi: 10.3390/ijms25042301.
10
Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.甲状旁腺功能亢进-颌骨肿瘤综合征的表型分析及分子机制
J Clin Endocrinol Metab. 2023 Nov 17;108(12):3165-3177. doi: 10.1210/clinem/dgad368.

引用本文的文献

1
ANO5 p.I616F variant drives florid cemento-osseous dysplasia by disrupting transmembrane domain structure.ANO5基因p.I616F变异通过破坏跨膜结构域结构导致 florid 型骨化性纤维瘤病。
BMC Oral Health. 2025 Aug 21;25(1):1345. doi: 10.1186/s12903-025-06717-5.
2
Hyperparathyroidism-Jaw Tumor Syndrome: A Rare Case Report and Literature Review.甲状旁腺功能亢进-颌骨肿瘤综合征:1例罕见病例报告及文献复习
Clin Case Rep. 2025 Apr 1;13(4):e70390. doi: 10.1002/ccr3.70390. eCollection 2025 Apr.
3
A Novel Pathogenic Gene Variant in Hyperparathyroidism-jaw Tumor Syndrome.

本文引用的文献

1
Two cases of multiple ossifying fibromas in the jaws.两例颌骨多发性骨化性纤维瘤。
Diagn Pathol. 2014 Mar 28;9:75. doi: 10.1186/1746-1596-9-75.
2
GNAS mutational analysis in differentiating fibrous dysplasia and ossifying fibroma of the jaw.GNAS 基因突变分析在颌面部纤维结构不良和骨化性纤维瘤鉴别诊断中的作用。
Mod Pathol. 2013 Aug;26(8):1023-31. doi: 10.1038/modpathol.2013.31. Epub 2013 Mar 15.
3
Assessing the contribution of HRPT2 to the pathogenesis of jaw fibrous dysplasia, ossifying fibroma, and osteosarcoma.评估 HRPT2 在颌面部纤维结构不良、骨化性纤维瘤和骨肉瘤发病机制中的作用。
甲状旁腺功能亢进-颌骨肿瘤综合征中的一种新型致病基因变异体。
JCEM Case Rep. 2025 Jan 24;3(2):luaf016. doi: 10.1210/jcemcr/luaf016. eCollection 2025 Feb.
4
Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.甲状旁腺功能亢进-颌骨肿瘤综合征的表型分析及分子机制
J Clin Endocrinol Metab. 2023 Nov 17;108(12):3165-3177. doi: 10.1210/clinem/dgad368.
5
Molecular and Clinical Spectrum of Primary Hyperparathyroidism.原发性甲状旁腺功能亢进的分子和临床谱。
Endocr Rev. 2023 Sep 15;44(5):779-818. doi: 10.1210/endrev/bnad009.
6
Genomic Profiling of the Craniofacial Ossifying Fibroma by Next-Generation Sequencing.颅面部骨化性纤维瘤的下一代测序基因组分析。
Head Neck Pathol. 2023 Sep;17(3):722-730. doi: 10.1007/s12105-022-01523-9. Epub 2023 Mar 16.
7
Association Between Parafibromin Expression and Presence of Brown Tumors and Jaw Tumors in Patients with Primary Hyperparathyroidism: Series of Cases with Review of the Literature.甲状旁腺腺瘤素表达与原发性甲状旁腺功能亢进症患者棕色瘤和颌骨肿瘤存在的相关性:系列病例并文献复习。
Am J Case Rep. 2022 Oct 22;23:e936135. doi: 10.12659/AJCR.936135.
8
First presentation of a frameshift mutation in the SETD2 gene of a juvenile psammomatoid ossifying fibroma (JPOF) associated with an aneurysmal bone cyst.首次在伴有动脉瘤样骨囊肿的青少年砂粒体型骨化性纤维瘤(JPOF)的 SETD2 基因中发现移码突变。
Diagn Pathol. 2021 Oct 17;16(1):91. doi: 10.1186/s13000-021-01160-w.
9
Parafibromin Abnormalities in Ossifying Fibroma.骨化性纤维瘤中的副纤维瘤蛋白异常
J Endocr Soc. 2021 May 8;5(7):bvab087. doi: 10.1210/jendso/bvab087. eCollection 2021 Jul 1.
10
The Unforeseen Diagnosis: Hyperparathyroidism-Jaw Tumour Syndrome Case Report and Review of the Literature.意外诊断:甲状旁腺功能亢进-颌骨肿瘤综合征病例报告及文献综述
Case Rep Endocrinol. 2021 May 20;2021:5551203. doi: 10.1155/2021/5551203. eCollection 2021.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Mar;115(3):359-67. doi: 10.1016/j.oooo.2012.11.015.
4
Synchronous ossifying fibromas of the jaws: a review.颌骨同步骨化性纤维瘤:综述。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Nov;114(5 Suppl):S120-5. doi: 10.1016/j.oooo.2011.08.007. Epub 2012 Feb 25.
5
Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.细胞分裂周期蛋白 73 同源物(CDC73)突变与甲状旁腺功能亢进-颌骨肿瘤综合征(HPT-JT)和甲状旁腺瘤有关。
Hum Mutat. 2010 Mar;31(3):295-307. doi: 10.1002/humu.21188.
6
The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene.副纤维瘤蛋白肿瘤抑制蛋白通过抑制原癌基因c-myc来抑制细胞增殖。
Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17420-5. doi: 10.1073/pnas.0710725105. Epub 2008 Nov 5.
7
Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice.副纤维瘤蛋白是人类PAF复合物的一个组成部分,它调节生长因子,并且是成年小鼠胚胎发育和生存所必需的。
Mol Cell Biol. 2008 May;28(9):2930-40. doi: 10.1128/MCB.00654-07. Epub 2008 Jan 22.
8
Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.副纤维瘤蛋白免疫反应性:其作为甲状旁腺肿瘤分类的额外诊断标志物的应用。
Endocr Relat Cancer. 2007 Jun;14(2):501-12. doi: 10.1677/ERC-07-0021.
9
Parafibromin tumor suppressor enhances cell growth in the cells expressing SV40 large T antigen.
Oncogene. 2007 Sep 13;26(42):6176-83. doi: 10.1038/sj.onc.1210445. Epub 2007 Apr 2.
10
Ossifying fibroma vs fibrous dysplasia of the jaw: molecular and immunological characterization.颌骨骨化性纤维瘤与骨纤维异常增殖症:分子与免疫学特征
Mod Pathol. 2007 Mar;20(3):389-96. doi: 10.1038/modpathol.3800753.